NRC Health Share Repurchase Program Excise Tax
NRC Health (NRC) reported Share Repurchase Program Excise Tax of $195.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes
us-gaap:ShareRepurchaseProgramExciseTax · last filed 2026-03-05
- NRC Health share repurchase program excise tax for fiscal 2025 was $195.00K, a 41.09% decline from fiscal 2024.
- NRC Health share repurchase program excise tax for fiscal 2024 was $331.00K, a 117.76% increase from fiscal 2023.
- NRC Health share repurchase program excise tax for fiscal 2023 was $152.00K.
| Period end | Share Repurchase Program Excise Tax 12 month | Share Repurchase Program Excise Tax 12 month as first filed |
|---|---|---|
| 2025-12-31 | $195.00K 10-K · filed 2026-03-05 | |
| 2024-12-31 | $331.00K 10-K · filed 2026-03-05 | $311.00K 10-K · filed 2025-03-17 |
| 2023-12-31 | $152.00K 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |